文献速递传染病防控与疫情报告

首次全球猴痘疫情描述:全球监测数据分析

Description of the first global outbreak of mpox: an analysis of global surveillance data.
PubMed 文献 · Lancet Glob Health · 2023-01-01

本文分析2022年1月1日至2023年1月29日WHO成员国经全球监测系统报告的全部确诊猴痘病例数据,共纳入82807例有病例报告表的病例。疫情主要由IIb分支猴痘病毒驱动,以男男性行为者中传播为主,最常见传播途径为性接触。住院风险在5岁以下儿童、65岁及以上老年人、女性及免疫抑制者中升高。

要点

  • 本次疫情主要由IIb分支猴痘病毒(主要谱系B.1,其次A.2)引起,通过新描述的传播方式扩散。
  • 病例主要为男性(76293例中73560例,96.4%),其中自我认同为男男性行为者占29854例中的25938例(86.9%)。
  • 最常见报告传播途径为性接触(21749例中14941例,68.7%)。

核心结论

  • 持续全球监测使WHO得以监测疫情、识别风险因素并指导公共卫生应对;本次疫情可归因于IIb分支猴痘病毒通过新描述的传播方式扩散。

研究设计与样本

  • 对2022年1月1日至2023年1月29日WHO成员国经全球监测系统报告的全部确诊猴痘病例的全球监测数据分析,纳入82807例有病例报告表的病例;采用多变量混合效应二元logistic回归分析住院风险因素,并回顾性分析传播趋势;使用GISAID和GenBank测序数据分析猴痘病毒遗传多样性。

主要发现

  • 病例主要由IIb分支猴痘病毒引起(主要谱系B.1,其次A.2);男性占76293例中的73560例(96.4%),自我认同为男男性行为者占29854例中的25938例(86.9%);最常见传播途径为性接触(21749例中14941例,68.7%);54117例中3927例(7.3%)住院。

关键数值与推荐

  • 住院风险升高:5岁以下调整比值比2.12(95%CI 1.32-3.40,p=0.0020);65岁及以上1.54(95%CI 1.05-2.25,p=0.026);女性1.61(95%CI 1.35-1.91,p<0.0001);HIV阳性且免疫抑制者2.00(95%CI 1.68-2.37,p<0.0001);其他免疫抑制状况者3.47(95%CI 1.84-6.54,p=0.0001)。

临床怎么用

  • 持续全球监测使WHO得以监测疫情、识别风险因素并指导公共卫生应对。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In May 2022, several countries with no history of sustained community transmission of mpox (formerly known as monkeypox) notified WHO of new mpox cases. These cases were soon followed by a large-scale outbreak, which unfolded across the world, driven by local, in-country transmission within previously unaffected countries. On July 23, 2022, WHO declared the outbreak a Public Health Emergency of International Concern. Here, we aim to describe the main epidemiological features of this outbreak, the largest reported to date. METHODS: In this analysis of global surveillance data we analysed data for all confirmed mpox cases reported by WHO Member States through the global surveillance system from Jan 1, 2022, to Jan 29, 2023. Data included daily aggregated numbers of mpox cases by country and a case reporting form (CRF) containing information on demographics, clinical presentation, epidemiological exposure factors, and laboratory testing. We used the data to (1) describe the key epidemiological and clinical features of cases; (2) analyse risk factors for hospitalisation (by multivariable mixed-effects binary logistic regression); and (3) retrospectively analyse transmission trends. Sequencing data from GISAID and GenBank were used to analyse monkeypox virus (MPXV) genetic diversity. FINDINGS: Data from 82 807 cases with submitted CRFs were included in the analysis. Cases were primarily due to clade IIb MPXV (mainly lineage B.1, followed by lineage A.2). The outbreak was driven by transmission among males (73 560 [96·4%] of 76 293 cases) who self-identify as men who have sex with men (25 938 [86·9%] of 29 854 cases). The most common reported route of transmission was sexual contact (14 941 [68·7%] of 21 749). 3927 (7·3%) of 54 117 cases were hospitalised, with increased odds for those aged younger than 5 years (adjusted odds ratio 2·12 [95% CI 1·32-3·40], p=0·0020), aged 65 years and older (1·54 [1·05-2·25], p=0·026), female cases (1·61 [1·35-1·91], p<0·0001), and for cases who are immunosuppressed either due to being HIV positive and immunosuppressed (2·00 [1·68-2·37], p<0·0001), or other immunocompromising conditions (3·47 [1·84-6·54], p=0·0001). INTERPRETATION: Continued global surveillance allowed WHO to monitor the epidemic, identify risk factors, and inform the public health response. The outbreak can be attributed to clade IIb MPXV spread by newly described modes of transmission. FUNDING: WHO Contingency Fund for Emergencies. TRANSLATIONS: For the French and Spanish translations of the abstract see Supplementary Materials section.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Laurenson-Schafer H, Sklenovská N, Hoxha A, et al. Description of the first global outbreak of mpox: an analysis of global surveillance data. Lancet Glob Health. 2023. PMID: 37349031. doi:10.1016/S2214-109X(23)00198-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。